PureTech Health Plc (LON:PRTC) Stock “Buy” Rating Reaffirmed at Liberum Capital; The Target Price per Share Given is GBX 248.00; Rudolph Technologies (RTEC) Has 0.88 Sentiment

PureTech Health Plc (LON:PRTC) had its stock rating noted as “Buy” by analysts at Liberum Capital. Liberum Capital currently has a GBX 248.00 target on the 385.71 million GBP market cap company or 52.38% upside potential. This was released in analysts note on Tuesday, 13 March.

Rudolph Technologies, Inc. designs, develops, makes, and supports process control defect inspection and metrology, advanced packaging lithography, and data analysis systems and software used in microelectronic device manufacturing. The company has market cap of $959.31 million. The firm also offers process and yield management solutions used in wafer processing and final manufacturing through standalone systems for macro-defect inspection, lithography, probe card test and analysis, and transparent and opaque thin film measurements. It has a 29.75 P/E ratio. In addition, it provides spare parts.

Ratings analysis reveals 0 of Rudolph Tech’s analysts are positive. Out of 2 Wall Street analysts rating Rudolph Tech, 0 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. RTEC was included in 2 notes of analysts from November 23, 2016. The firm has “Neutral” rating by Credit Suisse given on Monday, January 9. Stifel Nicolaus downgraded the stock to “Hold” rating in Wednesday, November 23 report.

Gagnon Advisors Llc holds 5.77% of its portfolio in Rudolph Technologies, Inc. for 289,547 shares. Tanaka Capital Management Inc owns 69,555 shares or 4.08% of their US portfolio. Moreover, Gagnon Securities Llc has 3.76% invested in the company for 399,394 shares. The California-based Malaga Cove Capital Llc has invested 1.96% in the stock. Pacific Ridge Capital Partners Llc, a Oregon-based fund reported 148,674 shares.

Analysts await Rudolph Technologies, Inc. (NYSE:RTEC) to report earnings on May, 7. They expect $0.36 EPS, up 50.00% or $0.12 from last year’s $0.24 per share. RTEC’s profit will be $11.38 million for 21.08 P/E if the $0.36 EPS becomes a reality. After $0.28 actual EPS reported by Rudolph Technologies, Inc. for the previous quarter, Wall Street now forecasts 28.57% EPS growth.

The stock increased 0.50% or $0.15 during the last trading session, reaching $30.35. About 215,970 shares traded. Rudolph Technologies, Inc. (RTEC) has risen 79.97% since March 13, 2017 and is uptrending. It has outperformed by 63.27% the S&P500.

Since January 1, 0001, it had 0 insider buys, and 4 selling transactions for $833,950 activity.

The stock decreased 1.55% or GBX 2.55 during the last trading session, reaching GBX 162.45. About 52,668 shares traded. PureTech Health plc (LON:PRTC) has 0.00% since March 13, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 5 analysts covering Puretech Health Plc (LON:PRTC), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Puretech Health Plc has GBX 313 highest and GBX 194 lowest target. GBX 257.60’s average target is 58.57% above currents GBX 162.45 stock price. Puretech Health Plc had 97 analyst reports since July 30, 2015 according to SRatingsIntel. Jefferies maintained PureTech Health plc (LON:PRTC) on Friday, November 17 with “Buy” rating. The firm has “Buy” rating by Jefferies given on Friday, June 9. The stock of PureTech Health plc (LON:PRTC) has “Buy” rating given on Thursday, July 30 by Jefferies. The stock of PureTech Health plc (LON:PRTC) earned “Buy” rating by Liberum Capital on Friday, November 4. Jefferies maintained PureTech Health plc (LON:PRTC) rating on Wednesday, December 21. Jefferies has “Buy” rating and GBX 255 target. On Thursday, December 15 the stock rating was maintained by Numis Securities with “Buy”. The stock of PureTech Health plc (LON:PRTC) has “Buy” rating given on Thursday, February 1 by Peel Hunt. The firm has “Buy” rating by Numis Securities given on Wednesday, August 30. The firm earned “Buy” rating on Wednesday, August 30 by N+1 Singer. The stock of PureTech Health plc (LON:PRTC) earned “Buy” rating by Peel Hunt on Thursday, November 30.